Market Cap 52.78B
Revenue (ttm) 321.33B
Net Income (ttm) 1.55B
EPS (ttm) N/A
PE Ratio 16.27
Forward PE 15.25
Profit Margin 0.48%
Debt to Equity Ratio 3.45
Volume 1,716,200
Avg Vol 1,856,136
Day's Range N/A - N/A
Shares Out 194.56M
Stochastic %K 79%
Beta 0.59
Analysts Strong Sell
Price Target $354.75

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distr...

Industry: Medical Distribution
Sector: Healthcare
Phone: 610 727 7000
Address:
1 West First Avenue, Conshohocken, United States
DidYouReadThis
DidYouReadThis Jun. 23 at 7:11 PM
$OTLK does anyone remember if $MCK had been mentioned before? $COR isn’t a surprise. Any guesses on potential other channel #partners? Good luck $OTLK on PDUFA Wednesday 7/29/26!
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 23 at 7:02 PM
$COR Current Stock Price: $279.51 Contracts to trade: $280.0 COR Jul 17 2026 Call Entry: $7.80 Exit: $14.16 ROI: 82% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Roxy123321
Roxy123321 Jun. 23 at 4:59 PM
$COR Will this go up or come down to where it was before?
0 · Reply
G101SPM
G101SPM Jun. 23 at 2:29 PM
#INSIDERS $COR Director bought 4,000 shares at $274.19 worth approximately $1.1 mln (transaction date 6/18). $LOVE President and one (1) Director bought 31,720 shares combined at $14.105 - $14.83 worth approximately $465K (transaction dates 6/18-6/22). $MSTR Chief Executive Officer bought 11,000 shares of Series A Perpetual Stretch Preferred Stock worth approximately $999K (transaction date 6/22). $JPM General Counsel sold 5,467 shares at $330.7337 worth approximately $1.8 mln (transaction date 6/22). $LWAY 10% owner sold 50,000 shares at $26.00 - $26.99 worth approximately $1.3 mln (transaction date 6/22).
0 · Reply
jontanaj
jontanaj Jun. 23 at 1:15 AM
$COR https://youtu.be/yipav-YwAsc?is=8OhThthkNnCK0ar5
0 · Reply
jhalimath61
jhalimath61 Jun. 22 at 10:54 PM
$COR 300 in August
1 · Reply
FilingTracker
FilingTracker Jun. 22 at 8:09 PM
$COR $1.1 million insider purchase: https://filingtracker.ai/filing/1140859/0001202358-26-000006
1 · Reply
DidYouReadThis
DidYouReadThis Jun. 12 at 4:03 PM
0 · Reply
cynicaloptimist
cynicaloptimist Jun. 8 at 12:50 AM
$COR 👁
0 · Reply
Cutlass
Cutlass Jun. 5 at 4:25 PM
$COR Another safe haven on red days - 🔎👀
0 · Reply
Latest News on COR
Cencora price target raised to $285 from $280 at BofA

2026-06-24T11:00:13.000Z - 22 hours ago

Cencora price target raised to $285 from $280 at BofA

CI MCK


Suncrete, Inc. Completes Arkansas Acquisition

Jun 15, 2026, 4:15 PM EDT - 9 days ago

Suncrete, Inc. Completes Arkansas Acquisition

RMIX


Cencora price target lowered to $350 from $425 at Barclays

2026-06-10T09:16:02.000Z - 15 days ago

Cencora price target lowered to $350 from $425 at Barclays


Cencora appoints Eva Boratto as CFO

2026-05-27T11:38:00.000Z - 4 weeks ago

Cencora appoints Eva Boratto as CFO


Cencora still sees long-term adjusted EPS growth of 10%-14%

2026-05-27T11:34:42.000Z - 4 weeks ago

Cencora still sees long-term adjusted EPS growth of 10%-14%


Cencora Announces Updated Fiscal Year 2026 Financial Outlook

May 21, 2026, 4:30 PM EDT - 4 weeks ago

Cencora Announces Updated Fiscal Year 2026 Financial Outlook


Cencora price target lowered to $339 from $420 at Baird

2026-05-07T16:03:22.000Z - 6 weeks ago

Cencora price target lowered to $339 from $420 at Baird


Cencora price target raised to $412 from $410 at UBS

2026-05-07T13:27:00.000Z - 6 weeks ago

Cencora price target raised to $412 from $410 at UBS


Cencora price target lowered to $355 from $405 at Citi

2026-05-07T11:17:45.000Z - 6 weeks ago

Cencora price target lowered to $355 from $405 at Citi


Cencora reports Q2 adjusted EPS $4.75, consensus $4.73

2026-05-07T09:39:48.000Z - 6 weeks ago

Cencora reports Q2 adjusted EPS $4.75, consensus $4.73


Cencora Earnings Call Transcript: Q2 2026

May 6, 2026, 8:30 AM EDT - 7 weeks ago

Cencora Earnings Call Transcript: Q2 2026


Cencora Earnings release: Q2 2026

May 6, 2026, 8:30 AM EDT - 7 weeks ago

Cencora Earnings release: Q2 2026


Cencora Slides: Q2 2026

May 6, 2026, 8:30 AM EDT - 7 weeks ago

Cencora Slides: Q2 2026


Cencora Quarterly report: Q2 2026

May 6, 2026, 8:30 AM EDT - 7 weeks ago

Cencora Quarterly report: Q2 2026


Cencora raises annual profit forecast despite quarterly miss

May 6, 2026, 7:41 AM EDT - 7 weeks ago

Cencora raises annual profit forecast despite quarterly miss


Cencora Reports Fiscal 2026 Second Quarter Results

May 6, 2026, 6:30 AM EDT - 7 weeks ago

Cencora Reports Fiscal 2026 Second Quarter Results


Cencora initiated with a Market Perform at William Blair

2026-04-28T10:11:54.000Z - 2 months ago

Cencora initiated with a Market Perform at William Blair


Cencora price target lowered to $360 from $420 at Evercore ISI

2026-04-08T13:22:35.000Z - 2 months ago

Cencora price target lowered to $360 from $420 at Evercore ISI


Cencora Announces Financial Leadership Transition

Mar 17, 2026, 8:30 AM EDT - 3 months ago

Cencora Announces Financial Leadership Transition


Cencora Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 2:20 PM EDT - 3 months ago

Cencora Transcript: Leerink Global Healthcare Conference 2026


Cencora Transcript: AGM 2026

Mar 5, 2026, 3:30 PM EST - 3 months ago

Cencora Transcript: AGM 2026


Covetrus and MWI Animal Health to Merge

Feb 18, 2026, 7:00 AM EST - 4 months ago

Covetrus and MWI Animal Health to Merge


Cencora Closes $3.0 Billion Senior Notes Offering

Feb 13, 2026, 4:15 PM EST - 4 months ago

Cencora Closes $3.0 Billion Senior Notes Offering


Cencora Earnings Call Transcript: Q1 2026

Feb 4, 2026, 8:30 AM EST - 5 months ago

Cencora Earnings Call Transcript: Q1 2026


Cencora Quarterly report: Q1 2026

Feb 4, 2026, 8:30 AM EST - 5 months ago

Cencora Quarterly report: Q1 2026


Cencora Earnings release: Q1 2026

Feb 4, 2026, 8:30 AM EST - 5 months ago

Cencora Earnings release: Q1 2026


Cencora Slides: Q1 2026

Feb 4, 2026, 8:30 AM EST - 5 months ago

Cencora Slides: Q1 2026


Cencora Reports Fiscal 2026 First Quarter Results

Feb 4, 2026, 6:30 AM EST - 5 months ago

Cencora Reports Fiscal 2026 First Quarter Results


Cencora Elects Ellen Cooper to Its Board of Directors

Jan 22, 2026, 7:30 AM EST - 5 months ago

Cencora Elects Ellen Cooper to Its Board of Directors


Cencora Proxy statement: Proxy Filing

Jan 22, 2026, 7:00 AM EST - 5 months ago

Cencora Proxy statement: Proxy Filing


Cencora Proxy statement: Proxy Filing

Jan 22, 2026, 7:00 AM EST - 5 months ago

Cencora Proxy statement: Proxy Filing


Cencora Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:00 PM EST - 5 months ago

Cencora Transcript: 44th Annual J.P. Morgan Healthcare Conference


Cencora Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:00 PM EST - 5 months ago

Cencora Slides: 44th Annual J.P. Morgan Healthcare Conference


Cencora Earnings Call Transcript: Q4 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

Cencora Earnings Call Transcript: Q4 2025


Cencora Annual report: Q4 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

Cencora Annual report: Q4 2025


Cencora Earnings release: Q4 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

Cencora Earnings release: Q4 2025


Cencora Slides: Q4 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

Cencora Slides: Q4 2025


Cencora Transcript: Baird Global Healthcare Conference 2025

Sep 9, 2025, 3:45 PM EDT - 10 months ago

Cencora Transcript: Baird Global Healthcare Conference 2025


Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Aug 27, 2025, 4:15 PM EDT - 10 months ago

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors


Cencora Earnings Call Transcript: Q3 2025

Aug 6, 2025, 8:30 AM EDT - 11 months ago

Cencora Earnings Call Transcript: Q3 2025


Cencora Earnings release: Q3 2025

Aug 6, 2025, 8:30 AM EDT - 11 months ago

Cencora Earnings release: Q3 2025


Cencora Quarterly report: Q3 2025

Aug 6, 2025, 8:30 AM EDT - 11 months ago

Cencora Quarterly report: Q3 2025


Cencora Slides: Q3 2025

Aug 6, 2025, 8:30 AM EDT - 11 months ago

Cencora Slides: Q3 2025


Cencora Reports Fiscal 2025 Third Quarter Results

Aug 6, 2025, 6:30 AM EDT - 11 months ago

Cencora Reports Fiscal 2025 Third Quarter Results


Cencora Elects Lori J. Ryerkerk to Its Board of Directors

May 28, 2025, 7:30 AM EDT - 1 year ago

Cencora Elects Lori J. Ryerkerk to Its Board of Directors


Cencora Earnings Call Transcript: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Cencora Earnings Call Transcript: Q2 2025


Cencora Quarterly report: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Cencora Quarterly report: Q2 2025


Cencora Earnings release: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Cencora Earnings release: Q2 2025


Cencora Slides: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Cencora Slides: Q2 2025


Cencora Reports Fiscal 2025 Second Quarter Results

May 7, 2025, 6:30 AM EDT - 1 year ago

Cencora Reports Fiscal 2025 Second Quarter Results


3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 1 year ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

CVS MCK PM


Cencora Earnings Call Transcript: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Cencora Earnings Call Transcript: Q1 2025


Cencora Quarterly report: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Cencora Quarterly report: Q1 2025


Cencora Earnings release: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Cencora Earnings release: Q1 2025


Cencora Slides: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Cencora Slides: Q1 2025


Cencora raises 2025 profit forecast on specialty drug demand

Feb 5, 2025, 7:23 AM EST - 1 year ago

Cencora raises 2025 profit forecast on specialty drug demand


Cencora Reports Fiscal 2025 First Quarter Results

Feb 5, 2025, 6:30 AM EST - 1 year ago

Cencora Reports Fiscal 2025 First Quarter Results


DidYouReadThis
DidYouReadThis Jun. 23 at 7:11 PM
$OTLK does anyone remember if $MCK had been mentioned before? $COR isn’t a surprise. Any guesses on potential other channel #partners? Good luck $OTLK on PDUFA Wednesday 7/29/26!
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 23 at 7:02 PM
$COR Current Stock Price: $279.51 Contracts to trade: $280.0 COR Jul 17 2026 Call Entry: $7.80 Exit: $14.16 ROI: 82% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Roxy123321
Roxy123321 Jun. 23 at 4:59 PM
$COR Will this go up or come down to where it was before?
0 · Reply
G101SPM
G101SPM Jun. 23 at 2:29 PM
#INSIDERS $COR Director bought 4,000 shares at $274.19 worth approximately $1.1 mln (transaction date 6/18). $LOVE President and one (1) Director bought 31,720 shares combined at $14.105 - $14.83 worth approximately $465K (transaction dates 6/18-6/22). $MSTR Chief Executive Officer bought 11,000 shares of Series A Perpetual Stretch Preferred Stock worth approximately $999K (transaction date 6/22). $JPM General Counsel sold 5,467 shares at $330.7337 worth approximately $1.8 mln (transaction date 6/22). $LWAY 10% owner sold 50,000 shares at $26.00 - $26.99 worth approximately $1.3 mln (transaction date 6/22).
0 · Reply
jontanaj
jontanaj Jun. 23 at 1:15 AM
$COR https://youtu.be/yipav-YwAsc?is=8OhThthkNnCK0ar5
0 · Reply
jhalimath61
jhalimath61 Jun. 22 at 10:54 PM
$COR 300 in August
1 · Reply
FilingTracker
FilingTracker Jun. 22 at 8:09 PM
$COR $1.1 million insider purchase: https://filingtracker.ai/filing/1140859/0001202358-26-000006
1 · Reply
DidYouReadThis
DidYouReadThis Jun. 12 at 4:03 PM
0 · Reply
cynicaloptimist
cynicaloptimist Jun. 8 at 12:50 AM
$COR 👁
0 · Reply
Cutlass
Cutlass Jun. 5 at 4:25 PM
$COR Another safe haven on red days - 🔎👀
0 · Reply
thefourpercent
thefourpercent Jun. 1 at 3:20 PM
$COR playing here again
0 · Reply
OnlyFibs
OnlyFibs Jun. 1 at 12:08 AM
$COR is an absolute cash-generating machine! Cencora just updated their fiscal 2026 outlook, raising EPS guidance and announcing a massive new $2.0 billion share repurchase program! The board is aggressively eating up their own float, and the market is officially waking up to the value here. Taking a look at the daily chart, this is a textbook reversal setup! Price found a hard bottom near the $242 level and is now violently hooking up with a powerful momentum shift off the lows. The tape has flipped, and it's coiling incredibly tight right below immediate overhead resistance! 📊🐋 🐂 Bulls: Need a decisive break and hold above the $271.00 resistance zone to spark a structural squeeze toward the $290 level! 🚀 🐻 Bears: A flush below the $250.00 support base traps the early dip buyers and resumes the heavy downtrend. 🛑 #COR #StockMarket #SwingTrading #hovdid
0 · Reply
jhalimath61
jhalimath61 May. 29 at 3:07 PM
$COR So 2Billion dollar buyback, guidance raised, insider buys 1 million on open market - and this is still going red. Such an easy buy at these levels. This is a beast of a healthcare stock and will be 300 plus in no time.
1 · Reply
thefourpercent
thefourpercent May. 28 at 1:05 PM
$COR order fulfilled
0 · Reply
thefourpercent
thefourpercent May. 28 at 11:42 AM
$COR I’m buying here expecting a 2% return this week
0 · Reply
DidYouReadThis
DidYouReadThis May. 26 at 4:04 PM
$OTLK $COR $ABC Oldie but a goodie
0 · Reply
OnlyFibs
OnlyFibs May. 25 at 10:23 PM
$COR is staging a violent V-shaped recovery after a catastrophic earnings gap-down, fueled by a massive new share repurchase program. 🌊 This is a high-conviction structural reset for the pharmaceutical distributor. While the top-line revenue miss and lowered guidance caused a historic haircut, management firing back with a $2B buyback authorization and raised EPS outlook has completely changed the algorithmic flow. Bottom-fishers are aggressively positioning for a mean-reversion squeeze back into the structural gap. 🎯 🐂 Bulls want to hold the 259.87 baseline to force a clean daily close over 274.91 targeting the heavy 289.02 supply block. 🐻 Bears need to crack 259.87 to kill the dead-cat bounce and trigger a retest of the 237.51 capitulation floor. 📊 Lean BULLISH. #cor #trading #hovdid
0 · Reply
BillionerOfKing
BillionerOfKing May. 25 at 5:49 PM
$COR Current Stock Price: $275.05 Contracts to trade: $280.0 COR Jun 18 2026 Call Entry: $5.40 Exit: $10.66 ROI: 97% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OnlyFibs
OnlyFibs May. 23 at 9:23 PM
Massive macro inflection test developing on $COR. The weekly frame for Cencora has flushed straight back down into a heavy multi-year horizontal support zone on high capitulation volume. 💊📈 📊 The Tape Facts: Earnings Beat: Q2 adjusted EPS printed a clean beat at $4.75 on a monstrous $78.4B in revenue, fueled by surging GLP-1 distribution. Capital Defense: Management officially raised full-year EPS guidance to $17.65-$17.90 and dropped a $1.0B share buyback authorization. 🎯 Key Levels to Confirm: 🐂 Bulls: Must defend this base and close above $234.50 to activate the OneOncology acquisition momentum and target the $252.18 shelf. 🐻 Bears: Need a weekly close below $221.43 to break the macro support line and force a rapid markdown down to the $205.50 floor. #Healthcare #SpecialtyPharma #ValueInvesting #TechnicalAnalysis #hovdid
0 · Reply
OnlyFibs
OnlyFibs May. 22 at 4:17 AM
👀 $COR might’ve just printed the capitulation candle. Huge flush Massive volume spike Immediate bounce attempt That combo always gets my attention. 📈 Trend: Neutral 🐂 Bulls need $267 then $274 for real continuation 🐻 Lose $250 and this probably revisits lows Feels like weak hands got completely washed out here 😭🔥 Could see a violent relief rally if market stays green. #hovdid
0 · Reply
jhalimath61
jhalimath61 May. 22 at 12:09 AM
$COR 2 billion in buybacks. I almost hope this stays down tomorrow so I can load.
0 · Reply
CapitalMonk
CapitalMonk May. 20 at 2:56 AM
$COR Price: $266.17 (+1.64%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±2.96% RSI: 26.8 | Momentum: Strong Downside Volume: -42.4% vs avg Volatility: 4.11% Support: $244.26 | Resistance: $312.97 Sourch: http://marketbaubles.com/
0 · Reply